|
Clonegene is a biotechnology company specialising in the discovery and development of innovative molecular tools for life science research and therapeutic applications. Our work is rooted in rigorous basic research that translates fundamental biological insights into cutting-edge technologies. Through our expertise in immunology, molecular biology, and protein engineering, we develop:
Novel Antibodies – We design and produce proprietary antibodies with enhanced specificity and affinity for research, diagnostic, and therapeutic applications.
Neoantigens – Our neoantigen discovery platform identifies tumour-specific antigens that enable next-generation cancer immunotherapy development and personalised medicine approaches.
DNA and RNA Enzymes – We engineer and characterise novel enzymes with unique activities on nucleic acids, providing essential tools for molecular biology research, diagnostics, and therapeutic development.
At Clonegene, our goal is to transform scientific inquiry into practical solutions that advance biomedical research and improve human health.
Many of our products can be licensed. Get in touch with us at:
office@clonegene.com
|